tiprankstipranks
Trending News
More News >
Neurogene (NGNE)
NASDAQ:NGNE
US Market

Neurogene (NGNE) Technical Analysis

Compare
546 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Neurogene’s (NGNE) Moving Averages Convergence Divergence (MACD) indicator is -1.67, suggesting Neurogene is a Sell.
Neurogene’s (NGNE) 20-Day exponential moving average is 11.64, while Neurogene’s (NGNE) share price is $11.36, making it a Sell.
Neurogene’s (NGNE) 50-Day exponential moving average is 14.81, while Neurogene’s (NGNE) share price is $11.36, making it a Sell.

Neurogene (NGNE) Pivot Points

Apr 16, 2025, 09:53 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.47
9.88
10.38
10.79
11.29
11.70
12.20
Fibonacci
9.88
10.22
10.44
10.79
11.13
11.35
11.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neurogene (NGNE) Moving Averages

Apr 16, 2025, 09:53 PM
Period
Simple
Exponential
MA5
10.25Buy
10.47Buy
MA10
9.54Buy
10.47Buy
MA20
11.79Sell
11.64Sell
MA50
15.36Sell
14.81Sell
MA100
18.00Sell
19.64Sell
MA200
30.24Sell
27.01Sell
Neurogene’s (NGNE) 10-Day exponential moving average is 10.47, while Neurogene’s (NGNE) share price is $11.36, making it a Buy.
Neurogene’s (NGNE) 100-Day exponential moving average is 19.64, while Neurogene’s (NGNE) share price is $11.36, making it a Sell.
Neurogene’s (NGNE) stock price is $11.36 and Neurogene’s (NGNE) 50-day simple moving average is 15.36, creating a Sell signal.
Neurogene’s (NGNE) stock price is $11.36 and Neurogene’s (NGNE) 100-day simple moving average is 18.00, creating a Sell signal.
Neurogene’s (NGNE) stock price is $11.36 and Neurogene’s (NGNE) 200-day simple moving average is 30.24, creating a Sell signal.

Neurogene (NGNE) Technical Indicators

Apr 16, 2025, 09:53 PM
Name
Value
Implied Action
RSI (14)
45.11
Neutral
STOCH (9,6)
86.12
Sell
STOCHRSI (14)
43.10
Neutral
MACD (12,26)
-1.67
Sell
ADX (14)
23.68
Neutral
Williams %R
-54.07
Buy
CCI (14)
-12.24
Neutral
ATR (14)
1.53
-
Ultimate Oscillator
55.15
Neutral
ROC
-29.62
Sell
Neurogene’s (NGNE) Relative Strength Index (RSI) is 45.11, creating a Neutral signal.
Neurogene’s (NGNE) Trend Strength Indicator (ADX) is 23.68, creating a Neutral signal.
Neurogene’s (NGNE) Commodity Channel Index (CCI) is -12.24, creating a Neutral signal.
Neurogene’s (NGNE) Price Rate of Change (ROC) is -29.62, creating a Sell signal.

FAQ

Is NGNE a Buy, Hold, or Sell?
Based on NGNE’s technical indicators, NGNE is a Sell.
    What is NGNE’s RSI (14)?
    NGNE’s RSI (14) is 45.11, which suggests NGNE is a Neutral.
      What is NGNE’s MACD?
      NGNE’s MACD is -1.67, which suggests NGNE is a Sell.
        What is NGNE’s 5-day moving average?
        NGNE’s 5-day moving average is 10.25, which suggests NGNE is a Buy.
          What is NGNE’s 20-day moving average?
          NGNE 20-day moving average is 11.79, which suggests NGNE is a Sell.
            What is NGNE’s 50-day moving average?
            NGNE’s 50-day moving average is 15.36, which suggests NGNE is a Sell.
              What is NGNE’s 200-day moving average?
              NGNE’s 200-day moving average is 30.24, which suggests NGNE is a Sell.
                What is NGNE’s Williams % R (14)?
                NGNE’s Williams % R (14) is -54.07, which suggests NGNE is a Buy.
                  What is NGNE’s CCI (14)?
                  NGNE’s CCI (14) is -12.24, which suggests NGNE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis